Authors: ADCES staff and reviewed by subject matter experts. Support provided by CeQur
January 2023
Most clinicians and people with diabetes are familiar with conventional insulin delivery devices like pens, smart pens and pumps. But not everyone is aware of the bolus-only insulin patch. This newer option offers a variety of potential benefits for a subset of insulin users that warrants a closer look.
The CeQur Simplicity insulin patch is currently the only product in this category. The patch is a small, easy to use and teach device that attaches to the user’s skin (typically the stomach) and administers up to two units of insulin on demand by manually clicking its side buttons.
The patch is indicated for mealtime and correction bolusing in people with diabetes who are 21 years and older. For those who also need basal insulin, it may be used along with an injected long-acting insulin.
FEATURES | DESCRIPTION |
Size | 2.5 inches long x 1.4 inches wide x 0.3 inches high, weighs 0.4 ounces |
Capacity | Minimum fill is 100units, maximum fill is 200 units |
Units used to prime device | 20 units |
Bolus Increment | 2 units |
Method of bolus delivery | Pinch both sides of device with pincer grasp |
Approved length of wear | Up to 3 days (replaces up to 9 mealtime injections with pen/syringe) |
Insulins approved for use in device | Humalog U100 or Novolog U100 |
Water resistance | 30 minutes at 3.28 feet (1 meter). Can be worn swimming, bathing, showering, but not in hot tubs |
Studies by CeQur show that participants:
A person looking for new options in insulin delivery and who:
Vision Issues: To ensure success, accommodations to help someone measure out the proper insulin dose needs to be provided by the care team for those with limited vision.
Dexterity Limitations: Additionally, accommodations to help someone measure out the proper insulin dose needs to be provided by the care team for those with dexterity limitations. The user needs to be able to fill the device with the proper amount of insulin every 3 days (or less), attach the device to their body using the reusable inserter, and pinch the 2 sides simultaneously to deliver the dose. Dexterity issues may impact a person’s ability to perform these tasks.
Skin Sensitivity: If a person has sensitive skin, having a patch adhered to the skin may require some additional attention to ensure proper skin health and decrease skin reactivity. There are products on the market to help with skin preparation, cleansing, and adhesive removal along with adherents and coverings to keep the patch attached for the wear period.
Low Tech = No data: For those working closely with health care providers and diabetes care and education specialists, there is no data available to share and review, which can make visits and future recommendations for insulin optimization a challenge. Consider using the CeQur Simplicity with a CGM.
To use CeQur Simplicity, these prescriptions are required:
For more specific prescription details, visit danatech’s CeQur product page.
CeQur Simplicity is covered on most commercial and Medicare Part D insurance plans as a pharmacy benefit. Where covered, most patients have a co-pay of $50 or less a month.
Recent online research indicates retail cost for 10 patches is around $380, or $38 per patch. Visit our CeQur product page for more information.
These are the 4 steps to follow:
The bolus-only insulin patch is another option for individuals taking insulin who need a low tech, convenient way to administer bolus insulin. Like all insulin delivery devices, the person’s preferences, lifestyle, and insurance coverage should be fully considered in order to determine the insulin delivery device that will give them the best long-term outcomes.
For more details, visit our CeQur product page and follow the links for training and education, affordability programs and more.
Device Overview & Training: Hands on with CeQur Simplicity, a 3-day wearable mealtime insulin patch
References
1. Bergenstal R, Peyrot M, Dreon, D. et.al. on behalf of the Calibra Study Group. 2019. Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen. Diabetes Technology and Therapeutics 21 (5):1-13.
2. Johnson ML, Dreon DM, Levy BL, et.al. 2018. Comparing Patch vs. Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles. Diabetes 2018 Jul; 67(Supplement 1).
Connected Insulin Device Certificate Program
Insulin Pump Therapy Online Course
DISCLAIMERS:
This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.
ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.